Saturday 17 October 2026 Export HRTX’s income statement to Excel — free account

Heron Therapeutics, Inc.

Heron Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $154.9 million, up 7.36% from fiscal 2024. In the quarter to June 2026, revenue grew 1.25%, EPS fell 93.6%, free cash flow grew 78.8% and total debt fell 18.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

0.36 0.02 −5.26%

Follow HRTX

Alert me

Market cap: $71.5M
P/E: 0.0×
Fwd P/E: −6.6×
Dividend yield: —
F-score: 4/9
Altman Z: −8.84
Beneish M: −2.40
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	0.54	1.01	1.40	1.38
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(36.98)	(98.52)	(23.60)	161.26
P/B ratio Full definition →	13.97	18.76	16.32	30.56
Price to Tangible BV Full definition →	13.97	18.76	16.32	30.56
EV/Sales Full definition →	1.20	1.65	2.01	1.93
EV/EBITDA Full definition →	0.00	0.00	0.00	78.04
EV/Operating CF Full definition →	(15.67)	(12.27)	(11.26)	(9.90)
EV/FCF Full definition →	(15.04)	(11.95)	(11.17)	(9.63)
Quick Ratio Full definition →	1.44	1.42	1.42	1.52
Current Ratio Full definition →	2.49	2.53	2.48	2.56
Net Debt/EBITDA Full definition →	(65.95)	(23.28)	136.24	(24.67)
Debt/Assets Full definition →	56.55%	57.52%	54.96%	56.10%
Debt/Equity Full definition →	20.65	15.50	9.81	9.38
Asset Turnover Full definition →	0.62	0.63	0.63	0.66
Operating CF/Net income Full definition →	0.40	0.19	3.11	(0.08)
Capex/Depreciation Full definition →	(0.26)	(0.65)	0.02	0.04
Research and Development Expense of Revenue Full definition →	7.17%	6.87%	9.23%	9.08%
Selling, General and Administrative Expense of Revenue Full definition →	67.53%	76.21%	63.28%	70.45%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	8.44%	8.57%	5.37%	7.46%
Graham Net Nets Full definition →	(0.19)	(0.05)	(0.02)	(0.02)
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(44.19%)	(21.94%)	(8.88%)	(5.99%)
Free Cash Flow Yield Full definition →	(14.77%)	(13.71%)	(12.83%)	(14.46%)
Revenue per Share Full definition →	0.20	0.18	0.24	0.22
Operating CF per Share Full definition →	(0.01)	(0.01)	(0.06)	0.01
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	(0.01)	(0.01)	(0.05)	0.01
Cash per Share Full definition →	0.22	0.24	0.28	0.33
Shareholders Equity per Share Full definition →	0.04	0.05	0.09	0.09
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	0.04	0.05	0.09	0.09
Free Cash Flow Full definition →	(2.35)	(1.93)	(9.17)	1.36
Working Capital Full definition →	137.70	138.47	141.97	139.69
Capital Expenditures Full definition →	(0.14)	(0.39)	0.02	0.03
Net Current Asset Value Full definition →	(15.51)	(8.09)	(3.48)	(4.66)
EV/EBIT Full definition →	0.00	0.00	0.00	187.11
Capex to Sales Full definition →	0.00	0.01	0.00	0.00
Price to Operating Income Full definition →	0.00	0.00	0.00	134.40
Other line items
Average Receivables Full definition →	84.75	81.21	84.23	74.04
Average Payables Full definition →	11.84	10.65	10.35	11.10
Average Inventory Full definition →	81.78	74.74	72.95	57.99
Average Assets Full definition →	242.18	240.98	244.51	234.86
Average Common Equity Full definition →	(10.70)	(10.18)	(10.18)	(16.49)

Show all line items

Columns are period end dates

Stockrow Weekly